| Mr Joseph Morris Iii, DO | |
|
1223 S Gear Ave, Ste 304, West Burlington, IA 52655 | |
| (319) 768-4380 | |
| (319) 768-4385 |
| Full Name | Mr Joseph Morris Iii |
|---|---|
| Gender | Male |
| Speciality | Nephrology |
| Experience | 22 Years |
| Location | 1223 S Gear Ave, West Burlington, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609843085 | NPI | - | NPPES |
| 1609843085 | Medicaid | IA | |
| P00623410 | Other | IA | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RN0300X | Internal Medicine - Nephrology | 3897 (Iowa) | Primary |
| 208M00000X | Hospitalist | 244366 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rai - Medical Drive-gloucester | Gloucester, VA | Dialysis facility |
| Riverside Walter Reed Hospital | Gloucester, VA | Hospital |
| Riverside Regional Medical Center | Newport news, VA | Hospital |
| St Lukes Regional Medical Center | Sioux city, IA | Hospital |
| Riverside Doctors' Hospital Of Williamsburg | Williamsburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Riverside Physician Services Inc | 5092608448 | 743 |
News Archive
According to a new report from Professor Mariana Mazzucato, Director of the UCL Institute for Innovation and Public Purpose (IIPP), in collaboration with STOPAIDS, Global Justice Now and Just Treatment, the NHS patients are not getting treatments at affordable process and this is a failure on part of the global health innovation system.
David H. Fater, CEO of Vicor Technologies, Inc., today announced that on July 23, 2009, the Australian Patent Office issued it a Deed of Letters Patent for its altered state physiology drug development platform. Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients at risk of sudden cardiac death and trauma victims in need of lifesaving intervention.
Gamida Cell announced today that the Gamida Cell-Teva Joint Venture has received an FDA Fast Track Designation for StemEx, in development as an alternative to a bone marrow transplant for patients with blood cancers such as leukemia and lymphoma.
Marya Lieberman, associate professor of chemistry and biochemistry at the University of Notre Dame, has received a Grand Challenges Explorations grant, an initiative funded by the Bill & Melinda Gates Foundation. Lieberman will pursue an innovative global health and development research project, titled "Printed test cards for rapid field screening of human and animal medications."
› Verified 3 days ago
| Entity Name | Riverside Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194929026 PECOS PAC ID: 5092608448 Enrollment ID: O20040207000400 |
News Archive
According to a new report from Professor Mariana Mazzucato, Director of the UCL Institute for Innovation and Public Purpose (IIPP), in collaboration with STOPAIDS, Global Justice Now and Just Treatment, the NHS patients are not getting treatments at affordable process and this is a failure on part of the global health innovation system.
David H. Fater, CEO of Vicor Technologies, Inc., today announced that on July 23, 2009, the Australian Patent Office issued it a Deed of Letters Patent for its altered state physiology drug development platform. Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients at risk of sudden cardiac death and trauma victims in need of lifesaving intervention.
Gamida Cell announced today that the Gamida Cell-Teva Joint Venture has received an FDA Fast Track Designation for StemEx, in development as an alternative to a bone marrow transplant for patients with blood cancers such as leukemia and lymphoma.
Marya Lieberman, associate professor of chemistry and biochemistry at the University of Notre Dame, has received a Grand Challenges Explorations grant, an initiative funded by the Bill & Melinda Gates Foundation. Lieberman will pursue an innovative global health and development research project, titled "Printed test cards for rapid field screening of human and animal medications."
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Joseph Morris Iii, DO Po Box 540, West Burlington, IA 52655 Ph: (319) 768-3200 | Mr Joseph Morris Iii, DO 1223 S Gear Ave, Ste 304, West Burlington, IA 52655 Ph: (319) 768-4380 |
News Archive
According to a new report from Professor Mariana Mazzucato, Director of the UCL Institute for Innovation and Public Purpose (IIPP), in collaboration with STOPAIDS, Global Justice Now and Just Treatment, the NHS patients are not getting treatments at affordable process and this is a failure on part of the global health innovation system.
David H. Fater, CEO of Vicor Technologies, Inc., today announced that on July 23, 2009, the Australian Patent Office issued it a Deed of Letters Patent for its altered state physiology drug development platform. Vicor Technologies is a biotechnology company focused on the commercialization of innovative, non-invasive medical devices and diagnostics using its patented, proprietary PD2i® nonlinear algorithm and software to stratify patients at risk of sudden cardiac death and trauma victims in need of lifesaving intervention.
Gamida Cell announced today that the Gamida Cell-Teva Joint Venture has received an FDA Fast Track Designation for StemEx, in development as an alternative to a bone marrow transplant for patients with blood cancers such as leukemia and lymphoma.
Marya Lieberman, associate professor of chemistry and biochemistry at the University of Notre Dame, has received a Grand Challenges Explorations grant, an initiative funded by the Bill & Melinda Gates Foundation. Lieberman will pursue an innovative global health and development research project, titled "Printed test cards for rapid field screening of human and animal medications."
› Verified 3 days ago
Dr. Mark L Woodard, D.O. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1223 S Gear Ave, Suite 109, West Burlington, IA 52655 Phone: 319-768-1820 | |
Zeina Hajar, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1223 S Gear Ave, West Burlington, IA 52655 Phone: 319-768-1000 | |
Dr. Anthony L Lazar, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1223 S Gear Ave, Suite 109, West Burlington, IA 52655 Phone: 319-754-4004 Fax: 319-753-5498 | |
Dr. Viren Mawoj Kumar Raheja, MBBS Nephrology Medicare: Medicare Enrolled Practice Location: 1225 S Gear Ave, West Burlington, IA 52655 Phone: 319-768-3700 | |
Shanmuga Priyan Vasudevan, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1221 S Gear Ave, West Burlington, IA 52655 Phone: 319-768-1000 | |
Dr. Maroun E El-khoury, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1225 S Gear Ave, Suite 152, West Burlington, IA 52655 Phone: 319-753-1220 Fax: 319-753-5464 | |
Mohamed A Gashouta, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1221 S Gear Ave, West Burlington, IA 52655 Phone: 319-850-7425 |